Press Release March 1, 2022Medexus Pharmaceuticals Announces Deal for Gleolan in the United States 0 0 Share
Press Release February 10, 2022Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021 0 0 Share
Company Ticker News February 2, 2022Medexus to Present at The MicroCap Rodeo's 2nd Annual Winter Wonderland Best Ideas Investor Conference 0 0 Share
Company Ticker News January 7, 2022Medexus to Present at the H.C. Wainwright BioConnect 2022 Conference 0 0 Share
Company Ticker News December 3, 2021Medexus to Participate in Two Upcoming Virtual Investor Conferences 0 0 Share
Press Release December 2, 2021Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac's Type A Meeting with FDA on Treosulfan 0 0 Share
Company Ticker News November 11, 2021Medexus Pharmaceuticals, Inc. (MEDXF) CEO Ken d'Entremont on Q2 2022 Results - Earnings Call Transcript 0 0 Share
Company Ticker News November 11, 2021Medexus Pharmaceuticals Reports Financial and Operational Results for the Three- and Six-Month Periods Ending September 30, 2021 0 0 Share
Company Ticker News November 10, 2021Medexus to Present at the Q4 Investor Summit on November 17th 0 0 Share
